Chapter 1
The Woman Behind the Immortal Cells
On a cold January day in 1951, Henrietta Lacks, a young Black woman, made her way to Johns Hopkins Hospital in Baltimore-one of the few places that would treat African Americans during that era of rigid segregation. She had discovered a hard lump on her cervix, which she described as a "knot." This visit would unknowingly alter the course of medical history.
Born Loretta Pleasant in 1920 (though she later became known as Henrietta), she grew up in a small wooden cabin in Clover, Virginia, that had once been the slave quarters of her white ancestors' tobacco plantation. After her mother's death when she was just four years old, Henrietta was raised by her grandfather alongside numerous cousins, including Day Lacks, whom she would later marry.
Life in rural Virginia revolved around tobacco farming. The children worked the fields from sunrise to sunset, and Henrietta left school after the sixth grade to join the full-time labor force. Despite the hardships, family members recall her vibrant spirit. She was known for her striking beauty, with smooth coffee-colored skin and a captivating smile. She loved to dance and cook, and was famous for her sweet potato pie.
By age 14, she had her first child with Day, and they eventually married and had five children together. When World War II created jobs in steel production, the couple joined the Great Migration north, settling in Turner Station, a thriving Black community near Baltimore's Bethlehem Steel plant. There, Day worked the furnaces while Henrietta raised their children and kept house.
What makes Henrietta's story remarkable isn't just her life, but what happened after her visit to Johns Hopkins. The doctor who examined her took a sample of her tumor without her knowledge or consent-a common practice at the time. Those cells were sent to Dr. George Gey's laboratory, where something unprecedented occurred: unlike other cell samples that died quickly, Henrietta's cells doubled every 24 hours and never stopped.
Chapter 2
The Birth of an Immortal Legacy
In the sterile confines of Dr. George Gey's laboratory at Johns Hopkins, a quiet revolution was brewing. For years, scientists had been trying to grow human cells outside the body, but all attempts had failed-cells would die within days. This persistent obstacle had stymied medical research for decades.
When Henrietta's cervical sample arrived at the lab, lab assistant Mary Kubicek processed it like countless others before, expecting the same disappointing outcome. She placed thin slices of the aggressive tumor into test tubes filled with culture medium, labeled them "HeLa" (the first two letters of Henrietta's first and last names), and placed them in an incubator.
What happened next astonished everyone. Instead of dying, Henrietta's cells multiplied at an extraordinary rate. They doubled every 24 hours, crowding their containers and demanding more space. Dr. Gey, initially cautious about announcing the breakthrough, soon realized he had something remarkable-the first immortal human cell line.
"It was amazing," one lab worker recalled. "Those cells just wouldn't stop growing."
The timing couldn't have been more fortuitous. The early 1950s marked the height of the polio epidemic, with parents terrified to let their children play outside during summer months. Jonas Salk had developed a potential vaccine but needed human cells to test it on. HeLa cells became the perfect testing ground, leading to the successful polio vaccine that would save countless lives.
Meanwhile, Henrietta's own health deteriorated rapidly. The cancer that made her cells so uniquely aggressive in the laboratory was equally aggressive in her body. Doctors attempted to treat her with radium implants-the standard but brutal cancer treatment of the time. She endured excruciating pain as the cancer spread throughout her body.
Imagine the cruel irony: as Henrietta lay dying, her cells were thriving in laboratories, beginning a journey that would take them around the world and even into space. By October 1951, just eight months after her diagnosis, Henrietta passed away at age 31, leaving behind five children, including her baby daughter Deborah, who was just over a year old.
Henrietta never knew about her cells' remarkable abilities. She was buried in an unmarked grave in Clover, Virginia, while her cells lived on, multiplying and dividing, again and again.
Chapter 3
The Storm: Death and Scientific Revolution
On October 4, 1951, Henrietta Lacks took her final breath at Johns Hopkins Hospital. Her body, ravaged by an unusually aggressive form of cervical cancer, had finally surrendered after months of excruciating pain. As her family gathered to mourn, they had no idea that parts of Henrietta would continue living-not spiritually, but biologically.
The day of her funeral in Clover, Virginia, a storm of unusual ferocity struck. Thunder boomed and lightning cracked the sky as her wooden coffin was lowered into the ground. Family members later recalled this as a sign-as if Henrietta herself was speaking through the tumult, marking her passage with nature's fury.
"The rain, it just poured down," her cousin recalled. "The thunder, oh my Lord, the thunder. It was like Henrietta was telling us something."
Meanwhile, in Dr. Gey's laboratory, Henrietta's cells continued their relentless multiplication. Just days after her death, Dr. Gey appeared on national television holding a vial of her cells, though he never mentioned her name. Instead, he spoke of the scientific potential these cells represented-the first human cells to grow outside the body indefinitely.
The scientific community immediately recognized the breakthrough. Researchers could now conduct experiments on human cells without involving actual human subjects. Soon, a production facility was established at the Tuskegee Institute (ironically, the same place where the infamous syphilis study was conducted), producing HeLa cells by the trillions.
When Jonas Salk developed his polio vaccine, HeLa cells were crucial to testing it. Before HeLa, researchers had to use monkeys for each test-an expensive, time-consuming process. With HeLa, they could rapidly test the vaccine in cell cultures, accelerating development dramatically. By 1954, the first mass production of the polio vaccine was underway, thanks in large part to Henrietta's cells.
The demand for HeLa cells grew exponentially. They were shipped to researchers around the world, becoming the standard laboratory workhorse for studying cancer, viruses, gene mapping, and countless other scientific pursuits. They were exposed to toxins, radiation, and infections. They were sent into space to study the effects of zero gravity on human cells.
Yet as HeLa cells revolutionized medicine, Henrietta's family remained in poverty, many unable to afford health insurance. Her children were placed with different relatives after her death, some suffering abuse and neglect. Her husband Day eventually remarried, but the family was fractured, and Henrietta became a fading memory-spoken of rarely and with hushed tones.
Chapter 4
The HeLa Factory: Cells That Changed the World
By the mid-1950s, what began as a small sample in Dr. Gey's lab had transformed into a global scientific phenomenon. The Tuskegee Institute established the first HeLa "factory," a massive operation producing trillions of Henrietta's cells weekly. These cells traveled across continents, powering research that would have been impossible just years earlier.
Picture this: massive rooms filled with incubators, technicians in white coats tending to bottles of pinkish-yellow fluid containing billions of Henrietta's cells. Each week, they shipped these cells to researchers for just $10 per vial-an amount that would be worth thousands in today's market.
The timing was perfect. The National Foundation for Infantile Paralysis (later renamed the March of Dimes) needed a reliable testing system for Jonas Salk's polio vaccine. HeLa cells provided the perfect solution. Scientists could expose the cells to the virus, then add the potential vaccine to see if it prevented infection. This process, which would have required countless monkeys and years of testing, could now be done rapidly in petri dishes.
"It was a turning point in the history of polio research," one scientist noted. "Without HeLa cells, the vaccine development might have taken years longer."
But polio was just the beginning. HeLa cells became essential to research in cancer, AIDS, the effects of radiation and toxic substances, gene mapping, and countless other scientific pursuits. When scientists needed to understand how human cells would react to a particular stimulus, they turned to HeLa.
The cells' extraordinary hardiness made them ideal for shipping worldwide. Unlike other cells that died easily during transport, HeLa cells survived journeys of days or weeks, arriving ready to grow. This durability, however, would later prove problematic in unexpected ways.
As demand grew, commercial biological supply companies began mass-producing HeLa cells, creating a multi-million-dollar industry. One vial of cells could generate millions more, which were frozen, packaged, and sold to laboratories around the world. Scientists who received these cells could thaw them, grow more, and continue their experiments indefinitely.
Have you ever wondered why medical advances seemed to accelerate so dramatically in the latter half of the 20th century? HeLa cells played a crucial role in this acceleration, providing researchers with living human cells that responded to experiments in ways that animal cells or chemical models never could.
Chapter 5
Hidden Identity: The Woman Behind the Cells
For nearly two decades after Henrietta's death, her identity remained largely unknown to the scientific world. Researchers simply knew the cells as "HeLa," with no connection to the woman who unwittingly provided them. In scientific papers and textbooks, when her name appeared at all, it was often incorrectly listed as "Helen Lane" or "Helen Larson"-a deliberate anonymization by some researchers or simple error by others.
This anonymity reflected the standard practices of the time. Patient consent for tissue samples wasn't required, and doctors rarely informed patients when their tissues were used for research. The concept of bioethics as we understand it today was in its infancy.
In 1953, a journalist writing about the polio vaccine mentioned "Henrietta Lakes" as the source of the important cells. The misspelling further obscured her identity, creating confusion that would persist for years. Meanwhile, her family remained completely unaware that her cells lived on, dividing and multiplying in laboratories worldwide.
The scientific community's focus remained squarely on the cells' remarkable properties rather than their source. HeLa cells were unusually hardy, growing not just in test tubes but on dust particles, pipette tips, and other researchers' cultures. They traveled through the air on dust particles and microscopic droplets, contaminating other cell cultures with their vigorous growth.
This contamination problem came to light dramatically in 1966 when geneticist Stanley Gartler dropped what became known as the "HeLa bomb" at a scientific conference. Using a genetic marker found primarily in Black Americans, he demonstrated that many supposedly distinct cell lines used in research were actually contaminated with HeLa cells. This revelation threatened to invalidate years of research and millions of dollars in funding.
"It's a technical problem we all share," Gartler announced to the shocked audience. "Most of these cell lines, perhaps all of these cell lines, may be HeLa cells."
The contamination crisis highlighted both the extraordinary vitality of Henrietta's cells and the lack of standardized practices in cell culture work. It would take years for the scientific community to develop proper containment protocols and authentication methods to prevent HeLa cells from overtaking other cultures.
Throughout these scientific developments, Henrietta's children grew up without their mother, facing hardships and struggling to understand the vague explanations they received about her illness and death. Cancer was rarely discussed openly in the 1950s, especially in their community, and the children were left with more questions than answers about what had taken their mother away.
Chapter 6
"It's Alive": The Family Discovers the Truth
In 1973, more than two decades after Henrietta's death, her family finally learned about HeLa cells through a bizarre coincidence. Bobbette Lacks, who had married Henrietta's son Lawrence, was at a dinner party when a friend's brother-in-law mentioned he worked at the National Cancer Institute.
"I work with HeLa cells every day," he said casually.
"HeLa-that's a person?" Bobbette asked.
"Yeah, a woman named Henrietta Lacks."
Bobbette froze. "Henrietta Lacks is my mother-in-law," she said.
The scientist was shocked. "I thought she died a long time ago."
"She did," Bobbette replied.
This chance conversation opened a floodgate of questions and concerns. How could Henrietta's cells still be alive? Why hadn't the family been told? And perhaps most disturbingly, what else might have been taken from her?
When Bobbette told her husband and his siblings, they were stunned. For Lawrence, Sonny, and Deborah, this revelation was both fascinating and frightening. Their mother, who had been reduced to fading photographs and sparse memories, was somehow still "alive" in laboratories worldwide.
Deborah, who had been just over a year old when her mother died, was particularly affected. "I tried to imagine my mother alive as those cells, but I couldn't," she later said. "I was too young when she died to remember anything about her."
The family's confusion deepened when Lawrence called Johns Hopkins seeking information. The person who answered the phone had never heard of Henrietta Lacks but knew about HeLa cells. The family was transferred from department to department, each person as confused as the last about the connection between this Black family from Baltimore and the famous cells.
Their concerns intensified after learning about the Tuskegee Syphilis Study, in which Black men were left untreated for syphilis without their knowledge as part of a government study. Was Henrietta part of some experiment too? Had she been deliberately infected with cancer?
These fears, while unfounded regarding Henrietta's initial cancer, reflected the deep mistrust many Black Americans felt toward the medical establishment-a mistrust rooted in historical abuses. For the Lacks family, the revelation about HeLa cells reopened wounds of loss while raising new questions about exploitation, consent, and who controls the human body after death.
Think about it: How would you feel if you discovered parts of your deceased parent were being bought and sold around the world, had been essential to countless medical breakthroughs, yet no one had ever bothered to inform your family?
Chapter 7
Exploitation and Ethics: The Moore Case Parallel
In 1976, a Seattle businessman named John Moore was diagnosed with hairy cell leukemia. His doctor at UCLA, David Golde, recommended removing his spleen as treatment. What Moore didn't know was that Golde had recognized something unusual in his cells-they produced proteins that might have significant commercial value.
After the surgery, Golde asked Moore to return repeatedly for follow-up visits, collecting samples of his blood, bone marrow, and other tissues. Moore, who lived in Seattle, made the expensive trips to Los Angeles believing they were necessary for his health. In reality, Golde was using Moore's cells to develop a cell line with extraordinary commercial potential.
When Moore discovered the truth-that Golde had patented a cell line from his tissues and stood to make millions-he sued. The case, Moore v. Regents of the University of California, wound its way through the courts for years, raising profound questions about who owns human tissues once they're removed from the body.
"I was harvested," Moore later said. "It's that simple."
The parallels to Henrietta Lacks were striking. Both had tissues taken without specific consent for research. Both tissues proved immensely valuable scientifically and commercially. Neither patient nor their families received compensation or recognition until years later.
But there were crucial differences too. Moore was a white, educated businessman with resources to fight back legally. Henrietta was a poor Black woman whose family didn't even know about her cells for decades. Moore was alive to advocate for himself; Henrietta's voice had been silenced by death.
In 1990, the California Supreme Court ruled against Moore, establishing that individuals do not have rights to tissues removed from their bodies. The court worried that ruling otherwise would hinder medical research by requiring researchers to track down every patient whose tissues they used.
Justice Arabian, though concurring with the majority, wrote separately to express his discomfort: "Plaintiff has asked us to recognize and enforce a right to sell one's own body tissue for profit. He entreats us to regard the human vessel-the single most venerated and protected subject in any civilized society-as equal with the basest commercial commodity."
The Moore case established a legal precedent that would later affect discussions about HeLa cells and compensation for the Lacks family. It highlighted the tension between advancing medical science and respecting individual autonomy-a tension that remains unresolved today.
For many bioethicists, both cases revealed a troubling pattern: scientific progress often came at the expense of fully informed consent, particularly for vulnerable populations. The question remained: How could society balance the need for medical advancement with respect for patients' rights and dignity?
Chapter 8
The Secret of Immortality: Understanding HeLa's Power
What made Henrietta's cells so special? This question has fascinated scientists for decades. Most human cells undergo about 50 divisions before dying-a phenomenon called "cellular senescence" discovered by Leonard Hayflick in the 1960s. HeLa cells, however, divide indefinitely.
The secret lies partly in telomeres-protective caps at the ends of chromosomes that shorten with each cell division, eventually signaling the cell to stop dividing. HeLa cells produce an enzyme called telomerase that rebuilds these telomeres, essentially resetting the cellular clock and allowing unlimited division.
But that's not the only factor. In 1984, German virologist Harald zur Hausen discovered that Henrietta's tumor contained multiple copies of human papillomavirus 18 (HPV-18), one of the most aggressive strains of HPV. The virus inserted its DNA into Henrietta's cells, disrupting their normal growth controls and contributing to both their cancerous nature and immortality.
"It was a perfect storm of factors," explains cancer researcher Robert Weinberg. "The HPV infection, combined with other genetic changes, created cells with extraordinary properties."
Over decades in culture, HeLa cells have continued to evolve. They now have between 76 and 80 chromosomes, compared to the normal 46 in human cells, and their genetic makeup has changed significantly from Henrietta's original cells. These changes have led some scientists to suggest they should be classified as a new species: Helacyton gartleri.
The cells' immortality raises profound questions about life, death, and identity. In a very real sense, part of Henrietta continues to live, though transformed beyond recognition. Her cells have been used to develop treatments for diseases she never heard of, traveled to space, and been exposed to nuclear radiation-experiences her conscious self never had.
For the Lacks family, particularly her daughter Deborah, these scientific explanations offered little comfort. They preferred a more spiritual interpretation-that Henrietta's cells lived on as part of God's plan, allowing her to help others even after death.
"I used to get so mad about them cells," Deborah once said. "But then I realized all the good they done for people, and I thought, That's what mama would have wanted."
The immortality of HeLa cells also raises questions about the future of medicine. If we could harness the mechanisms that make these cells immortal-but control them to prevent cancer-could we extend human lifespan? Could we grow replacement organs that never wear out? The scientific possibilities remain both tantalizing and ethically complex.
Chapter 9
The Lacks Family's Journey: Pain and Reconciliation
While HeLa cells traveled around the world advancing science, Henrietta's children struggled with poverty, lack of education, and the absence of their mother. After her death, the family fractured. Her husband Day eventually remarried, but the children faced various hardships.
Elsie, Henrietta's second child who had developmental disabilities, was placed in the Hospital for the Negro Insane (later renamed Crownsville State Hospital), where she died at age 15 under mysterious circumstances. Decades later, Deborah would discover that Elsie likely suffered abuse and may have been subjected to experiments without consent.
The three boys-Lawrence, Sonny, and Zakariyya (born Joe)-and daughter Deborah were raised partly by their father and partly by different relatives. Some experienced physical and sexual abuse. Zakariyya, born shortly before Henrietta's cancer diagnosis, carried particular resentment, believing his birth somehow triggered her illness.
"She went to the hospital to have me, and they found that cancer," he later said. "I always thought it was something I done, coming out and making her sick."
Education was a casualty for most of the children. None completed high school initially, though some would later earn GEDs. Without education, they worked in low-paying jobs, struggling to support their own families. The irony was stark: while their mother's cells helped create a multibillion-dollar industry and saved countless lives, her children couldn't afford basic healthcare.
When they finally learned about HeLa cells in the 1970s, their reactions varied. Lawrence and Sonny were primarily concerned about possible exploitation and compensation. Zakariyya harbored deep anger toward the medical establishment. But Deborah, who had almost no memories of her mother, became obsessed with learning everything she could about Henrietta and her cells.
"I want to know, who was my mother?" Deborah would say repeatedly. "I don't want to just hear she was sick and died."
Her quest for knowledge led her to collect newspaper clippings, scientific articles, and anything else mentioning HeLa cells. Though she had limited education, she tried to understand the science, carrying a dictionary to look up medical terms. Her efforts were often met with condescension from scientists who didn't know how to explain complex concepts to someone without scientific training.
The family's journey toward reconciliation with their mother's legacy took a significant turn when they were invited to Johns Hopkins to see HeLa cells for themselves. Christoph Lengauer, a cancer researcher, showed them the cells under a microscope and explained their importance to medicine.
"You're famous," he told them. "Just nobody knows it's you."
For Zakariyya, who had harbored the most anger, seeing his mother's cells was transformative. "They're beautiful," he said, his voice softening. "I never thought I'd see my mother under a microscope-I never dreamed this day would come."
Chapter 10
Healing and Legacy: Coming to Terms with Immortality
For Deborah Lacks, the journey to understand her mother's legacy became all-consuming. She suffered anxiety attacks, developed hives, and experienced periods of paranoia-all stemming from the emotional weight of discovering her mother's cells lived on without the family's knowledge. Yet she persevered, driven by a deep need to connect with the mother she barely remembered.
"I think about my mother's cells growing all over the world," she once said. "I think, they're a part of me, my mother's part of me. I did come from her."
When author Rebecca Skloot entered the picture, seeking to tell Henrietta's story, Deborah was initially hesitant. The family had been approached by journalists and researchers before, often feeling exploited afterward. But Skloot's persistence and genuine interest in Henrietta as a person, not just her cells, eventually won Deborah's trust.
Together, they embarked on a journey of discovery-visiting Clover where Henrietta grew up, tracking down medical records, and even finding documentation about Elsie's time at Crownsville. Each discovery brought both pain and healing. Learning about the horrific conditions Elsie endured was devastating, but finding a photograph of her sister brought Deborah indescribable joy.
"This is the most important thing that happened to me in my life," Deborah said, holding the photo. "This is my sister. This is proof that she was here."
The family's spiritual beliefs provided another avenue for healing. Deborah's cousin Gary, a deeply religious man, helped her see her mother's cells as part of God's plan-a way for Henrietta to fulfill a divine purpose by helping others even after death.
"The Bible says eternal life is a gift from God," Gary explained. "When I look at those cells under the microscope, I'm looking at her body, at her spiritual body. Those cells are Henrietta."
This spiritual interpretation offered comfort that scientific explanations couldn't provide. For the Lacks family, HeLa wasn't just a scientific phenomenon but a continuation of Henrietta's spirit and purpose.
Gradually, the scientific community began to acknowledge its ethical debt to Henrietta and her family. In 2001, the National Foundation for Cancer Research established the Henrietta Lacks Award. Johns Hopkins, while never offering financial compensation, created programs honoring her contribution and providing her descendants with some involvement in decisions about HeLa research.
In 2013, after the publication of Skloot's book brought international attention to the story, the National Institutes of Health reached an unprecedented agreement with the Lacks family. They would have some control over access to the HeLa genome and acknowledgment in scientific papers that use the cells. While not financial compensation, it represented a historic recognition of a family's right to have some say in research using their loved one's biological material.
Deborah didn't live to see this agreement. She died in 2009, having fulfilled her mission to learn about her mother and ensure Henrietta's name would be remembered. Before her death, she told Skloot, "When people hear about my mother, they always say, 'Oh y'all could be rich! Y'all gotta sue Johns Hopkins!' But I don't want that. I just want to know who my mother was."
Chapter 11
The Enduring Questions: Ethics, Race, and Science Today
The story of Henrietta Lacks and her immortal cells continues to raise profound questions about the intersection of science, ethics, race, and economics. These questions aren't historical footnotes-they remain urgently relevant in today's world of advanced biotechnology and personalized medicine.
Consider this: at this very moment, millions of tissue samples are stored in biobanks across the country. When you have blood drawn for tests or a biopsy performed, leftover samples often go into storage for potential research use. Most patients, like Henrietta, have no idea their tissues might be used this way.
The legal landscape established by cases like Moore v. Regents of the University of California maintains that once tissues leave your body, you no longer have rights to them. Yet many people feel instinctively that they should have some say in how parts of their body are used, especially if those uses lead to commercial profit.
"There's something fundamentally wrong with the idea that your body can be taken from you without your permission and used for profit by others," argues bioethicist Harriet Washington, author of "Medical Apartheid."
The racial dimensions of Henrietta's story can't be ignored. Would a white woman's cells have been taken and used without consent in the same way? Would her family have been kept in the dark for decades? The history of medical research in America includes numerous examples of exploitation of Black bodies, from the Tuskegee Syphilis Study to J. Marion Sims's gynecological experiments on enslaved women.
Today, Black Americans remain underrepresented in clinical trials yet overrepresented in non-consensual tissue collection. This paradox-exclusion from the benefits of research while being disproportionately subjected to its risks-continues to fuel distrust of the medical establishment in many communities.
The economic questions are equally troubling. HeLa cells have generated billions in profits for pharmaceutical companies and biotechnology firms. Patents derived from research using HeLa cells have created enormous wealth. Yet Henrietta's descendants struggled to afford basic healthcare-some couldn't even afford health insurance.
"We're not trying to get rich," Henrietta's grandson told a reporter. "But it would be nice if we could get health insurance."
Various solutions have been proposed. Some advocate for a system where tissue donors receive a percentage of profits from commercial applications. Others suggest community benefit funds, where companies using human tissues contribute to healthcare access or education in the communities from which the tissues came.
The scientific community has made progress in addressing these issues. Informed consent procedures are more rigorous now, though they still rarely address commercial applications of tissue research. Institutional review boards provide oversight of research ethics, though their effectiveness varies.
Perhaps the most important legacy of Henrietta Lacks's story is how it has changed the conversation around research ethics. Medical students now learn about HeLa cells not just as a scientific breakthrough but as a cautionary tale about the importance of treating patients with dignity and transparency.
As we enter an era of increasingly personalized medicine, where our genetic information becomes central to healthcare, the questions raised by Henrietta's story become even more pressing. Who owns our biological information? Who should profit from it? How do we balance scientific progress with individual rights?
These aren't just academic questions-they're deeply personal ones that each of us may face in our lifetimes. The immortal life of Henrietta Lacks continues to challenge us to find better answers.
